Relationship between Acute Phase Proteins and Serum Fatty Acid Composition in Morbidly Obese Patients

Table 3

Serum fatty acid composition (%) of morbidly obese subjects studied (𝑛=21).

Fatty acid	Mean ± SD; (% of total fatty acids)	Min–Max
SFA
C12:0 (lauric acid)	17.1±3.4	8.7–22.3
C14:0 (myristic acid)	4.8±0.7	2.9–6.0
C16:0 (palmitic acid)	21.5±3.3	16.8–23.9
C17:0 (margaric acid)	0.4 (0.3–1.0)^a	0.1–1.0
C18:0 (stearic acid)	4.1±1.2	2.3–6.5
MUFA
C16:1 n-7 (palmitoleic acid)	20.7±3.1	14.2–25.3
C18:1 n-9 (oleic acid)	15.2±2.0	11.2–16.6
n-3 PUFA
C20:5 n-3 (EPA)	1.2 (1.1–1.7)^a	0.9–1.9
C22:6 n-3 (DHA)	2.8±0.5	1.9–3.1
n-6 PUFA
C18:2 n-6 (linoleic acid)	3.8 (3.0–4.4)^a	2.4–4.8
C20:4 n-6 (AA)	8.2±2.1	5.1–8.9
n-6/n-3	2.9±0.8	1.5–5.0
AA/EPA	6.5±2.5	3.4–12.5
PUFA/SFA	0.3±0.1	0.2–0.5

AA: arachidonic acid; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; SFA: saturated fatty acids SD: standard deviation. Min: minimum; Max: maximum.
aMedian (interquartile range).